Terms: = Brain cancer AND CD274, PDL1, 29126, ENSG00000120217, PDCD1L1, PD-L1, MGC142296, PDCD1LG1, MGC142294, B7H1, Q9NZQ7, B7-H AND Prognosis
166 results:
1. Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker.
Dai L; Xiao J; Li X; Tao Y; Zhou P; Lyu L; Shi Z; Liang X; Jia Z; Jiang S
J Gene Med; 2024 May; 26(5):e3685. PubMed ID: 38686653
[TBL] [Abstract] [Full Text] [Related]
2. Predictive Value of NLR and PLR in Driver-Gene-Negative Advanced Non-Small Cell Lung cancer Treated with PD-1/pd-l1 Inhibitors: A Single Institutional Cohort Study.
Yuan Q; Xu C; Wang W; Zhang Q
Technol Cancer Res Treat; 2024; 23():15330338241246651. PubMed ID: 38613344
[TBL] [Abstract] [Full Text] [Related]
3. Potential value of expression of receptor accessory protein 4 for evaluating the prognosis of lower-grade glioma patients.
Luo S; Liu Z; Chang H; Cheng X; Qian R; Gao Y; Hou C
Aging (Albany NY); 2024 Mar; 16(7):6188-6211. PubMed ID: 38552216
[TBL] [Abstract] [Full Text] [Related]
4. Gastroesophageal Adenocarcinomas With Defective Mismatch Repair: Current Knowledge and Clinical Management.
Strickland MR; Lander EM; Gibson MK; Ilson DH; Ajani JA; Klempner SJ
J Natl Compr Canc Netw; 2024 Mar; 22(3):. PubMed ID: 38503041
[TBL] [Abstract] [Full Text] [Related]
5. Integrative analysis of the cuproptosis-related gene ATP7B in the prognosis and immune infiltration of IDH1 wild-type glioma.
Zhang K; Qu C; Zhou P; Yang Z; Wu X
Gene; 2024 May; 905():148220. PubMed ID: 38286269
[TBL] [Abstract] [Full Text] [Related]
6. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
7. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
[TBL] [Abstract] [Full Text] [Related]
8. The Association of Immune Cell Infiltration with Metastasis Location in De Novo Metastatic Triple Negative Breast cancer: A Multicenter Cross-Sectional Study in Indonesia.
Tenggara JB; Rachman A; Prihartono J; Lisnawati L; Panigoro SS; Heriyanto DS; Steven R; Tandarto K; Juanputra S; Sudoyo AW
Acta Med Indones; 2023 Oct; 55(4):376-384. PubMed ID: 38213050
[TBL] [Abstract] [Full Text] [Related]
9. TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy.
Wang S; Xiong Y; Zhang Y; Wang H; Chen M; Li J; Luo P; Luo YH; Hecht M; Frey B; Gaipl U; Li X; Zhao Q; Ma H; Zhou JG
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38212124
[TBL] [Abstract] [Full Text] [Related]
10. pd-l1 (SP142) Expression in Primary and Recurrent/Metastatic Triple-Negative Breast cancers and Its Clinicopathological Significance.
Han EK; Woo JW; Suh KJ; Kim SH; Kim JH; Park SY
Cancer Res Treat; 2024 Apr; 56(2):557-566. PubMed ID: 38097920
[TBL] [Abstract] [Full Text] [Related]
11. Predictive value of CCL2 in the prognosis and immunotherapy response of glioblastoma multiforme.
Deng L; Ren J; Li B; Wang Y; Jiang N; Wang Y; Cui H
BMC Genomics; 2023 Dec; 24(1):746. PubMed ID: 38057698
[TBL] [Abstract] [Full Text] [Related]
12. GSDMA at the crossroads between pyroptosis and tumor immune evasion in glioma.
Zhang R; Song Q; Lin X; Du B; Geng D; Gao D
Biochem Biophys Res Commun; 2023 Dec; 686():149181. PubMed ID: 37924669
[TBL] [Abstract] [Full Text] [Related]
13. Immunotherapy and brain metastasis in lung cancer: connecting bench side science to the clinic.
Rios-Hoyo A; Arriola E
Front Immunol; 2023; 14():1221097. PubMed ID: 37876939
[TBL] [Abstract] [Full Text] [Related]
14. Clinical implications of RAB13 expression in pan-cancer based on multi-databases integrative analysis.
Zhang XD; Liu ZY; Luo K; Wang XK; Wang MS; Huang S; Li RF
Sci Rep; 2023 Oct; 13(1):16859. PubMed ID: 37803063
[TBL] [Abstract] [Full Text] [Related]
15. Impact of SPARC expression on treatment response of pembrolizumab and brain metastasis in patients with metastatic non-small cell lung cancer.
Goktas Aydin S; Bilici A; Calis E; Kutlu Y; Hamdard J; Muglu H; Fatih Olmez O; Karci E; Acikgoz O
Int Immunopharmacol; 2023 Nov; 124(Pt B):110947. PubMed ID: 37742369
[TBL] [Abstract] [Full Text] [Related]
16. Development of a prognostic model for anoikis and identifies hub genes in hepatocellular carcinoma.
Zhong Z; Xie F; Yin J; Zhao H; Zhou Y; Guo K; Li R; Wang Q; Tang B
Sci Rep; 2023 Sep; 13(1):14723. PubMed ID: 37679418
[TBL] [Abstract] [Full Text] [Related]
17. Progress of immune checkpoint inhibitors therapy for non-small cell lung cancer with brain metastases.
Yan X; Qu F; Zhou Y
Lung Cancer; 2023 Oct; 184():107322. PubMed ID: 37611495
[TBL] [Abstract] [Full Text] [Related]
18. Meta-analysis of PD-(L)1 inhibitor plus chemotherapy versus chemotherapy as first-line treatment in extensive-stage small-cell lung cancer.
Lu J; Lei X; Zhang P; Du L; Zhang Z; Qu B
Cancer Med; 2023 Sep; 12(17):17924-17933. PubMed ID: 37563966
[TBL] [Abstract] [Full Text] [Related]
19. Gasdermin D Plays an Oncogenic Role in Glioma and Correlates to an Immunosuppressive Microenvironment.
Li M; Jiang P; Wei S; Yang Y; Xiong L; Wang J; Li C
Biomolecules; 2023 May; 13(6):. PubMed ID: 37371484
[TBL] [Abstract] [Full Text] [Related]
20. E-cadherin expression in the tumor microenvironment of advanced epidermal growth factor receptor-mutant lung adenocarcinoma and the association with prognosis.
Chang YP; Huang GK; Chen YC; Huang KT; Chen YM; Lin CY; Huang CC; Lin MC; Wang CC
BMC Cancer; 2023 Jun; 23(1):569. PubMed ID: 37340370
[TBL] [Abstract] [Full Text] [Related]
[Next]
